(Q37399586)

20 August 2017

1 reference

title

Epilepsy and hormones: a critical review (English)

1 reference

20 August 2017

Gerhard Luef

1

1 reference

20 August 2017

Markus Rauchenzauner

series ordinal

2

1 reference

20 August 2017

publication date

21 February 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

15

1 reference

20 August 2017

issue

1

1 reference

20 August 2017

page(s)

73-77

1 reference

Epilepsy syndrome, focus location, and treatment choice affect testicular function in men with epilepsy

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Reproductive endocrine disorders in women with primary generalized epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Characterization of reproductive endocrine disorders in women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Ovulatory Function in Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Sensitivity and specificity of the association between catamenial seizure patterns and ovulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Temporal lobe epilepsy: an extrahypothalamic pathogenesis for polycystic ovarian syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Reproductive endocrine disorders in women with partial seizures of temporal lobe origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Obesity and endocrine disorders in women taking valproate for epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Hyperandrogenism, postprandial hyperinsulinism and the risk of PCOS in a cross sectional study of women with epilepsy treated with valproate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Bone health in people with epilepsy: is it impaired and what are the risk factors?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Brain-type natriuretic peptide secretion following febrile and afebrile seizures - a new marker in childhood epilepsy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

The ketogenic diet in children with Glut1 deficiency syndrome and epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Progressive bone deficit in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Interactions between hormones and epilepsy in female patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Endocrine effects of valproate in adolescent girls with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Serum sex hormone levels after replacing carbamazepine with oxcarbazepine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Metabolic and hormonal disturbances in women with epilepsy on antiepileptic drug monotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Reproductive and metabolic disorders in women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Fertility in persons with epilepsy: 1935-1974.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

A relationship between particular reproductive endocrine disorders and the laterality of epileptiform discharges in women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Relationship of sexual dysfunction to epilepsy laterality and reproductive hormone levels in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Differential effects of antiepileptic drugs on sexual function and reproductive hormones in men with epilepsy: interim analysis of a comparison between lamotrigine and enzyme-inducing antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Menstrual disorders in women with epilepsy receiving carbamazepine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Serum hormones in male epileptic patients receiving anticonvulsant medication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Carbamazepine, Phenytoin, Sex Hormones, and Sexual Function in Men with Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Effects of carbamazepine and oxcarbazepine on the reproductive endocrine function in women with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Serum steroid hormones and pituitary function in female epileptic patients during carbamazepine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Reversible effects of antiepileptic drugs on reproductive endocrine function in men and women with epilepsy--a prospective randomized double-blind withdrawal study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Interictal and postictal circadian and ultradian luteinizing hormone secretion in men with temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Sexual function in men with epilepsy: how important is testosterone?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Valproate, weight gain and carbohydrate craving: a gender study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Leptin and insulin homeostasis in epilepsy: relation to weight adverse conditions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Increase in postprandial serum insulin levels in epileptic patients with valproic acid therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Adiponectin and visfatin concentrations in children treated with valproic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Soluble leptin receptor and soluble receptor-bound fraction of leptin in the metabolic syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Adipocytokines: mediators linking adipose tissue, inflammation and immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Weight-reducing effects of the plasma protein encoded by the obese gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Soluble Leptin Receptor Represents the Main Leptin Binding Activity in Human Blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Adiponectin: more than just another fat cell hormone?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Plasma adiponectin concentrations in children: relationships with obesity and insulinemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Leptin, ghrelin, and adiponectin in epileptic patients treated with valproic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

More fat and fewer seizures: dietary therapies for epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Worldwide use of the ketogenic diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Sudden unexpected death in epilepsy: a review of incidence and risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Epilepsy and sudden death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Risk factors in sudden death in epilepsy (SUDEP): the quest for mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Sudden unexpected deaths in epilepsy--where are we now?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Circadian variation in heart-rate variability in localization-related epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Ictal bradycardia in partial epileptic seizures: Autonomic investigation in three cases and literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Heart rate variability during interictal epileptiform discharges.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Cardiac troponin levels following monitored epileptic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Evidence of cardiac ischemia during seizures in drug refractory epilepsy patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Assessment of heart failure with plasma natriuretic peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Pressor effect of blocking atrial natriuretic peptide in nucleus tractus solitarii

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Human brain natriuretic peptide-like immunoreactivity in human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Brain-type natriuretic peptide release and seizure activity during vagal nerve stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Incidence of Fractures among Epilepsy Patients: A Population-based Retrospective Cohort Study in the General Practice Research Database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Anti-epileptic medication and bone health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Bone health in women with epilepsy: clinical features and potential mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Gender differences in bone mineral density in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Bone in idiopathic and symptomatic epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Effect of antiepileptic drugs on bone density in ambulatory patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Increased bone turnover in epileptic patients treated with carbamazepine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Bone density and markers of bone turnover in predicting fracture risk and how changes in these measures predict fracture risk reduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Bone markers and current laboratory assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

The evaluation of thyroid functions, thyroid antibodies, and thyroid volumes in children with epilepsy during short-term administration of oxcarbazepine and valproate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Risk factors for development of subclinical hypothyroidism during valproic acid therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Thyroid hormones in children with epilepsy during long-term administration of carbamazepine and valproate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

Valproate-induced insulin resistance in prepubertal girls with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.022

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEBEH.2009.02.022

1 reference

20 August 2017

1 reference